The oncogene ERG: a key factor in prostate cancer

P Adamo, MR Ladomery - Oncogene, 2016 - nature.com
ETS-related gene (ERG) is a member of the E-26 transformation-specific (ETS) family of
transcription factors with roles in development that include vasculogenesis, angiogenesis …

Aberrant RNA splicing in cancer and drug resistance

BD Wang, NH Lee - Cancers, 2018 - mdpi.com
More than 95% of the 20,000 to 25,000 transcribed human genes undergo alternative RNA
splicing, which increases the diversity of the proteome. Isoforms derived from the same gene …

A novel urine exosome gene expression assay to predict high-grade prostate cancer at initial biopsy

J McKiernan, MJ Donovan, V O'Neill, S Bentink… - JAMA …, 2016 - jamanetwork.com
Importance Overdiagnosis and overtreatment of indolent prostate cancer (PCA) is a serious
health issue in most developed countries. There is an unmet clinical need for noninvasive …

Identification of a candidate gene panel for the early diagnosis of prostate cancer

GHJM Leyten, D Hessels, FP Smit, SA Jannink… - Clinical cancer …, 2015 - AACR
Abstract Purpose: Serum PSA (sPSA) testing has led to the identification of patients with
indolent prostate cancer, and inevitably overtreatment has become a concern. Progensa …

A molecular signature of PCA3 and ERG exosomal RNA from non-DRE urine is predictive of initial prostate biopsy result

MJ Donovan, M Noerholm, S Bentink… - Prostate cancer and …, 2015 - nature.com
Background: New screening methods that can add predictive diagnostic value for
aggressive (high-grade, Gleason score⩾ 7) prostate cancer (PCa) are needed to reduce …

Pathway-guided analysis identifies Myc-dependent alternative pre-mRNA splicing in aggressive prostate cancers

JW Phillips, Y Pan, BL Tsai, Z Xie… - Proceedings of the …, 2020 - National Acad Sciences
We sought to define the landscape of alternative pre-mRNA splicing in prostate cancers and
the relationship of exon choice to known cancer driver alterations. To do so, we compiled a …

A urine-based Exosomal gene expression test stratifies risk of high-grade prostate Cancer in men with prior negative prostate biopsy undergoing repeat biopsy

J McKiernan, M Noerholm, V Tadigotla, S Kumar… - BMC urology, 2020 - Springer
Background Initial prostate biopsy often fails to identify prostate cancer resulting in patient
anxiety, especially when clinical features such as prostate specific antigen (PSA) remain …

Association of ERG and TMPRSS2‐ERG with grade, stage, and prognosis of prostate cancer is dependent on their expression levels

A Font‐Tello, N Juanpere, S De Muga, M Lorenzo… - The …, 2015 - Wiley Online Library
BACKGROUND There is controversy in the literature on the role of the fusion TMPRSS2‐
ERG in the pathogenesis and progression of prostate cancer. The quantitative differences in …

RNA splicing and splicing regulator changes in prostate cancer pathology

J Munkley, K Livermore, P Rajan, DJ Elliott - Human genetics, 2017 - Springer
Abstract Changes in mRNA splice patterns have been associated with key pathological
mechanisms in prostate cancer progression. The androgen receptor (abbreviated AR) …

Androgen-driven fusion genes and chimeric transcripts in prostate cancer

M Scaravilli, S Koivukoski, L Latonen - Frontiers in Cell and …, 2021 - frontiersin.org
Androgens are steroid hormones governing the male reproductive development and
function. As such, androgens and the key mediator of their effects, androgen receptor (AR) …